Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4aripiprazole

02 1brexpiprazole

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Otsuka Pharmaceutical

NDC Package Code : 46602-0025

Start Marketing Date : 2012-09-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (300mg/1.5mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Otsuka Pharmaceutical

NDC Package Code : 46602-0072

Start Marketing Date : 2014-10-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (400mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Otsuka Pharmaceutical

NDC Package Code : 46602-0045

Start Marketing Date : 2014-10-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (300mg/1.5mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Otsuka Pharmaceutical

NDC Package Code : 46602-0026

Start Marketing Date : 2012-09-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE (400mg/2mL)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

05

2024 ACI Convention
Not Confirmed
arrow